Diabetes

Edit Answers
12345678910111213141516171819202122232425262728293031323334353637383940414243
Across
  1. 2. Phenomenon of blood glucose elevation at around 5-6AM caused by nigh time release of growth hormone
  2. 4. ... maneuver; teach patient with retinopathy to avoid this maneuver because it increases blood pressure ---> causing vitreuos hemorrhage
  3. 7. this type of symptoms result from autonomic nervous activity triggered by a rapid decline in blood glucose; such as: shaky/ tremulous, heart pounding, sweaty, hungry, tingling
  4. 9. plasma glucose test that is used for nonpregnant adults; patient requires to stop eating 8 hours before test ( Test needs to be done twice of value > 126 mg/dL to be dx as DM)
  5. 13. Test that reflects the amount of glucose binding to serum protein; is helpful in indicating tight control of blood glucose
  6. 14. microvascular complication leading to nerve dysfunction
  7. 17. Burning, stinging, or stabbing pain / Sensory alteration / Distal symmetric polyneuropathy
  8. 21. Increased fat deposits in the skin, often caused by not rotating insulin injection site
  9. 22. Excessive thirst
  10. 24. Delay in gastric emptying - one of the cause of hypoglycemia
  11. 29. A drug in the alpha-glucosidase inhibitors class
  12. 30. Initial antidiabetic therapy that's recommended to DM type 2; is a type of insulin sensitizers
  13. 32. amount of time ( in minutes) insulin Lispro,or Aspart should be given before meal-time (spell number out)
  14. 33. Focal ischemia / Manifestation such as: pain, asymmetric weakness; wasting of iliopsoas, quadriceps, and adductor muscles
  15. 36. Type of respiration r/t metabolic acidosis
  16. 37. Presence of albumin in urine, indication of kidney damage
  17. 41. main counterregulatory hormone; overtime type1 DM patients' pancreas lose the ability to make this hormone in response to hypoglycemia
  18. 42. when this substance is present in urine, DM patient should not exercise
  19. 43. a type of insulin sensitizers that increases cellular utilization of glucose; side effects are increase in adipose tissue, fluid retention and weight gain
Down
  1. 1. age-related farsightedness, often made worse by burred vision caused by fluctuating blood glucose
  2. 3. The fastest absorption site of insulin injection
  3. 5. Excessive eating
  4. 6. Condition that's defined as having IFG of 100-125 mg/dL, and IGT of 140-199mg/dL
  5. 8. Frequent and excessive urination
  6. 10. Neuropathy type that affects a single nerve or nerve entrapment
  7. 11. Burning, tingling sensation that starts out in toes and moves up the extremities ( Sensory alterations / Distal symmetric polynneuropathies)
  8. 12. Phenomenon of morning hyperglycemia from the counterregulatory response to nighttime hypoglycemia
  9. 15. a test that measures how much glucose permanently attaches to a specific area of hemoglobin
  10. 16. Basal insulin coverage is often provided by this type of insulin
  11. 18. common type of electrolyte imbalances, often seen in patients with mild to moderate kidney failure
  12. 19. Type of neuropathy that involve widespread nerve function ( the most common neuropathy in DM patient)
  13. 20. this type of symptoms occur when brain glucose gradually declines to a low level; such as: weakness, difficulty thinking, confusion, seizures, loss of consciousness
  14. 23. abbreviation of a diabetic condition that is characterized by uncontrolled hyperglycemia, metabolic acidosis, and increased production of ketones. This condition results from the combination of insulin deficiency and an increase in counterregulatory hormones.
  15. 25. Insulin secretagogue agent that stimulates insulin release; second-generation agents are often used
  16. 26. Often is the first indicator of chronic graft injection; presence of protein in urine
  17. 27. microvascular complication leading to vision problem
  18. 28. Route of administration of Increatin mimetics and amylin
  19. 31. abbreviation of a hyperglycemia state caused by hyperglycemia
  20. 34. Route of administration of meglitinide analogs, metformin, alpha-glucosidase inhibitors, TZDs, DPP-4 inhibitors...
  21. 35. This long-acting type of insulin should NOT be mixed with any other forms of insulin
  22. 37. Increased protein or nitrogen waste products in the blood
  23. 38. Short-acting antidiabetic med that increases insulin secretion
  24. 39. microvascular complication leading to kidney dysfunction
  25. 40. the most common precipitating factor for development of DKA